- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
RPG Life Sciences Limited — Updates, 13-07-2026: Press Release
13-07-2026 | 12:36 pm
13-07-2026 | 12:36 pm
RPG Life Sciences partnered with Archerchem Healthcare to launch Naprosyn ES, a novel combination drug for the first time in India. This product offers anti-inflammatory relief with gastro-protection, targeting long-term NSAID users and strengthening RPG LS's chronic therapy portfolio.
No comments yet. Be the first to comment!